The prospectus will be published week 49
The prospectus being produced on the basis of the rights issue, announced on November 18, 2019, is expected to be published week 49. Previous preliminary date of publication was November 29, 2019.
Please visit https://brighter.se/investors/benefit-issue for more information about the rights issue.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, firstname.lastname@example.org, www.eminova.se.
For further information, please contact:
Ann Zetterberg, CFO
Phone: +46 708 37 21 23
Henrik Norström, CEO
Phone: +46 733 40 30 45